Summary
Sixty patients with mastalgia, either idiopathic or secondary to dysplastic lesions, were treated with oral nimesulide (100mg tablets twice daily) for 15 days. Breast tension and pain, assessed at baseline and on completion of the treatment period, improved or resolved with therapy. Indeed, breast pain (which most likely manifests as a consequence of periductal inflammation) was most noticeably reduced. The drug was well tolerated in nearly all patients. These results support the usefulness of nimesulide and other nonsteroidal anti-inflammatory drugs in the treatment of mastalgia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bagnoli P. A proposito delle mastodinie. Minerva Medica 71: 2725–2728, 1980
Capsoni F, Venegoni E, Minonzio F, Ongari AM, Maresca V, et al. Inhibition of neutrophil oxidative metabolism by nimesulide. Agents and Actions 21: 121–129, 1987
Ciardetti P, Zucconi G, Bonazza M, Amunni G, Massi GB. L’etofenarnato nella terapia antalgica della displasia benigna della mammella. Oncologia Ginecologica 2: 219–226, 1983
Cole EN, Sellwood RA, England PC, Griffith K. Serum prolactin concentrations in benign breast disease throughout the menstrual cycle. European Journal of Cancer 13: 597–603, 1977
Gateley CA, Mansel RE. Management of the painful and nodular breast. British Medical Bulletin 47: 284–294, 1991
Golinger RC. Hormone and pathophysiology of fibrocystic mastopathy. Surgery Gynecology and Obstetrics 146: 273–285, 1978
Haagensen CD. In Diseases of the breast, 2nd ed., W.B. Saunders, Philadelphia, 1971
Halbreich U, Bendavid M, Assael M, Bormstein R. Serum prolactin in women with premenstrual syndrome. Lancet 2: 654–656, 1976
Huskisson EC. Measurement of pain. Lancet 2: 1127–1131, 1974
Mauvais-Jarvis P, Kuttenn M, Mowszowics I, Sitruk-Ware R. Mastopathies bénignes: étude hormonale chez 125 malades. Nouvelle Presse Médicale 6: 4115–4118, 1977
Preece PE, Baum M, Mansel RE, Webster DJT, Fortt RW, et al. Importance of mastalgia in operable breast cancer. British Medical Journal 284: 1299–1300, 1982
Preece PR, Hughes LE, Mansel RE, Baum M, Bolton PM, et al. Clinical syndromes of mastalgia. Lancet 1: 670–673, 1976
Rolland PH, Martin PM, Bourry M, Serment H. Prostaglandines et masthopathie bénigne. Journal de Gynécologie Obstétrique et Biologie de la Reproduction 10: 197–201, 1981
Rufer C, Schillinger E, Böttcher I, Repenthin W, Herrman C. Non-steroidal anti-inflammatories — XII. Mode of action of antiinflammatory methane sulfonanilides. Biochemical Pharmacology 31: 3591–3596, 1982
Sforza M, Perelli Ercolini M, D’Alessandro G. La mastalgia. Minerva Medica 69: 3395–3397, 1978
Swingle KF, Moore GGI, Grant TJ. 4-nitro-2-phenoxymethane-sulfonanilide (R-805): a chemically novel anti-inflammatory agent. Archives Internationales de Pharmacodynamie et de Therapie 221: 132–139, 1976
Tinozzi S, Rovati L, Valesi MG. La mastalgia: studio clinico su di un gruppo di donne in età premenopausale e suo tratta-mento. Chirurgia Italiana 34: 1–4, 1983
Zucconi G, Ciardetti P, Amunni G, Bonazza M, Massi GB. La mastodinia. Aspetti patogenetici e terapeutici. Oncologia Ginecologica 2: 193–202, 1983
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gabbrielli, G., Binazzi, P., Scaricabarozzi, I. et al. Nimesulide in the Treatment of Mastalgia. Drugs 46 (Suppl 1), 137–139 (1993). https://doi.org/10.2165/00003495-199300461-00030
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199300461-00030